
Vikas Lifecare (VIKASLIFE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.4B
Gross Profit
46.6M
3.45%
Operating Income
-217.1M
-16.06%
Net Income
-28.2M
-2.09%
Balance Sheet Metrics
Total Assets
7.3B
Total Liabilities
2.0B
Shareholders Equity
5.3B
Debt to Equity
0.37
Cash Flow Metrics
Revenue & Profitability Trend
Vikas Lifecare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 4.8B | 4.5B | 4.8B | 3.0B | 749.9M |
Cost of Goods Sold | 4.6B | 4.2B | 4.5B | 2.9B | 637.6M |
Gross Profit | 150.3M | 264.8M | 243.2M | 101.6M | 112.4M |
Gross Margin % | 3.1% | 5.9% | 5.1% | 3.4% | 15.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 52.1M | 35.2M | 59.8M | 11.9M |
Other Operating Expenses | 322.2M | 103.3M | 57.3M | 26.6M | 14.8M |
Total Operating Expenses | 322.2M | 155.4M | 92.5M | 86.4M | 26.7M |
Operating Income | -283.4M | 6.8M | 87.5M | -20.8M | 70.8M |
Operating Margin % | -5.9% | 0.2% | 1.8% | -0.7% | 9.4% |
Non-Operating Items | |||||
Interest Income | - | 5.2M | 9.3M | 5.9M | 2.4M |
Interest Expense | 45.7M | 28.7M | 23.0M | 13.8M | 38.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -128.7M | 170.8M | -213.7M | 390.9M | -15.0M |
Income Tax | -19.5M | 36.3M | -58.6M | 101.4M | 20.0M |
Effective Tax Rate % | 0.0% | 21.2% | 0.0% | 25.9% | 0.0% |
Net Income | -109.2M | 134.5M | -155.1M | 289.5M | -35.0M |
Net Margin % | -2.3% | 3.0% | -3.3% | 9.6% | -4.7% |
Key Metrics | |||||
EBITDA | -15.6M | 52.6M | 150.5M | 5.2M | 73.1M |
EPS (Basic) | ₹-0.04 | ₹0.10 | ₹-0.12 | ₹0.31 | ₹-0.04 |
EPS (Diluted) | ₹-0.04 | ₹0.09 | ₹-0.12 | ₹0.31 | ₹-0.04 |
Basic Shares Outstanding | 1857668560 | 1473907000 | 1306006000 | 934412000 | 795503402 |
Diluted Shares Outstanding | 1857668560 | 1473907000 | 1306006000 | 934412000 | 795503402 |
Income Statement Trend
Vikas Lifecare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 57.3M | 138.4M | 96.1M | 77.0M | 1.9M |
Short-term Investments | 374.4M | 21.0M | 17.0M | 9.7M | 35.0M |
Accounts Receivable | 1.3B | 1.5B | 1.7B | 427.5M | 712.6M |
Inventory | 48.0M | 92.1M | 125.3M | 284.9M | 271.7M |
Other Current Assets | 906.6M | 471.3M | 206.6M | 1.0K | - |
Total Current Assets | 2.7B | 2.4B | 2.3B | 1.2B | 1.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 363.4M | 303.0M | 216.3M | 0 | 0 |
Goodwill | 277.5M | 286.9M | 296.3M | 180.3M | 0 |
Intangible Assets | 68.7M | 78.1M | 87.5M | 150.8M | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 490.2M | -4.0K | -3.0K | 2.0K | - |
Total Non-Current Assets | 4.6B | 3.2B | 2.3B | 2.0B | 273.4M |
Total Assets | 7.3B | 5.5B | 4.5B | 3.2B | 1.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 597.6M | 147.6M | 588.0M | 666.4M | 376.6M |
Short-term Debt | 378.8M | 167.8M | 208.4M | 207.3M | 255.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 375.9M | -1.0K | 3.2K | -2.0K | -1.0K |
Total Current Liabilities | 1.5B | 534.3M | 1.1B | 1.0B | 659.3M |
Non-Current Liabilities | |||||
Long-term Debt | 388.2M | 177.1M | 95.6M | 23.5M | 162.0M |
Deferred Tax Liabilities | 0 | 1.6M | 4.2M | 91.3M | 814.0K |
Other Non-Current Liabilities | 39.0M | -2.0K | 1.0K | 45.0M | -1.0K |
Total Non-Current Liabilities | 433.7M | 228.4M | 148.7M | 164.9M | 163.5M |
Total Liabilities | 2.0B | 762.7M | 1.2B | 1.2B | 822.8M |
Equity | |||||
Common Stock | 1.9B | 1.7B | 1.4B | 1.1B | 663.5M |
Retained Earnings | - | 192.9M | 49.0M | 202.6M | 14.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.3B | 4.8B | 3.3B | 2.0B | 666.7M |
Key Metrics | |||||
Total Debt | 767.0M | 344.9M | 304.1M | 230.8M | 417.6M |
Working Capital | 1.2B | 1.9B | 1.2B | 172.8M | 556.8M |
Balance Sheet Composition
Vikas Lifecare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -131.0M | 239.7M | -214.1M | 390.6M | -15.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | -1.8M | - | - | - | - |
Working Capital Changes | -2.7B | 5.0M | -1.2B | -437.1M | 981.6M |
Operating Cash Flow | -2.9B | 263.0M | -1.4B | -36.9M | 1.0B |
Investing Activities | |||||
Capital Expenditures | -119.5M | 65.4M | 125.0K | -16.2M | -14.7M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | -828.9M | -391.8M | -675.1M | - |
Investment Sales | 1.2B | 0 | 3.4M | 346.4M | 131.0M |
Investing Cash Flow | 1.1B | -754.6M | -379.1M | -338.8M | 120.6M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | 72.1M | - | 107.0M |
Debt Repayment | - | - | -45.9M | -351.9M | -96.2M |
Financing Cash Flow | 913.8M | 1.3B | 1.5B | 398.4M | 10.8M |
Free Cash Flow | -2.3B | -577.2M | -1.3B | -281.0M | -91.6M |
Net Change in Cash | -915.0M | 821.3M | -269.4M | 22.6M | 1.1B |
Cash Flow Trend
Vikas Lifecare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
62.00
Price to Book
0.60
Price to Sales
0.86
PEG Ratio
-0.44
Profitability Ratios
Profit Margin
-2.21%
Operating Margin
-16.06%
Return on Equity
-2.16%
Return on Assets
-2.76%
Financial Health
Current Ratio
1.77
Debt to Equity
14.39
Beta
-0.58
Per Share Data
EPS (TTM)
₹-0.04
Book Value per Share
₹3.67
Revenue per Share
₹1.81
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
vikaslife | 4.1B | 62.00 | 0.60 | -2.16% | -2.21% | 14.39 |
Venky's (India | 21.2B | 18.21 | 1.44 | 8.20% | 3.53% | 11.50 |
Andrew Yule | 13.0B | 97.44 | 4.76 | -0.84% | -0.91% | 31.10 |
Apex Frozen Foods | 7.0B | 178.38 | 1.41 | 0.78% | 0.48% | 14.69 |
Mishtann Foods | 6.5B | 1.95 | 0.68 | 44.10% | 24.24% | 4.89 |
Mangalam Global | 5.3B | 22.75 | 2.64 | 11.46% | 0.96% | 111.39 |
Financial data is updated regularly. All figures are in the company's reporting currency.